Consuming a vegetarian diet lowered LDL-C, HbA1C, and body weight when compared to a

During separate panel discussions at McKesson ideaShare 2023, pharmacists discussed advocacy for pharmacy benefit manager

The use of psilocybin and psychedelic therapy can be a helpful tool for individuals with

Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but

Pharmacists can recognize evidence of successful interventions and learn how to integrate them into their

The approval marks the first monoclonal antibody approved to protect all infants through their first

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is

Not only is a combination of in-office visits and telemedicine an effective model of

Study among the first to examine delayed or missed pediatric preventative care during COVID-19

The approval of RiVive naloxone hydrochloride nasal spray for nonprescription use provides another tool to

Exercise alone or vitamin D supplementation did not clinically improve cognition in adults with mild

The new RSV vaccines are expected to be available in fall 2023.

The risk could double if the conditions are met, with deaths more common in women

The prolonged lack of viral exposure has likely increased the pool of children and adults

Through previous literature, investigators found that intervention with nutritional supplements may help to improve cognitive

August's Condition Watch focuses on skin health.

It is the first vaccine of its kind to be FDA approved, and it met

Most participants who received retatrutide lost a considerable amount of body weight; however, individual results

Cases address questions about how to relieve dry eyes.

Understanding the virus protein’s insertion mechanisms can be useful in creating new COVID-19

Researchers have identified new uses for insulin sensitizers, including in the treatment of polycystic ovary

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that

Products include Nirsevimab-alip, Remdesivir, Inclisiran, and Lecanemab-irmb.

In addition to identifying strategies to reduce the adverse effects of sleep and circadian disruption

With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have

In clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms

Clinically meaningful lowering of blood pressure through reduction in dietary sodium was achieved safely and

The approval marks the first authorized at-home sample collection test for sexually transmitted diseases

It will be interesting to see RSV hospitalization rates over this upcoming season following the

This innovation could be useful for optimizing the collaboration between patients with asthma and their

Continuing education and networking can help pharmacists stay current with the profession

The investigators found that perceived racism in everyday life was not associated with a higher